These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27322195)

  • 1. Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site.
    Bohdan N; Espín S; Águila S; Teruel-Montoya R; Vicente V; Corral J; Martínez-Martínez I
    PLoS One; 2016; 11(6):e0157834. PubMed ID: 27322195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase, heparin and the coagulation system in cancer progression.
    Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
    Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes.
    Futamura A; Beechem JM; Gettins PG
    Biochemistry; 2001 Jun; 40(22):6680-7. PubMed ID: 11380263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin.
    Izaguirre G; Swanson R; Raja SM; Rezaie AR; Olson ST
    J Biol Chem; 2007 Nov; 282(46):33609-33622. PubMed ID: 17875649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease.
    Izaguirre G; Aguila S; Qi L; Swanson R; Roth R; Rezaie AR; Gettins PG; Olson ST
    J Biol Chem; 2014 Dec; 289(49):34049-64. PubMed ID: 25331949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
    Savion N; Disatnik MH; Nevo Z
    J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.
    Olson ST; Richard B; Izaguirre G; Schedin-Weiss S; Gettins PG
    Biochimie; 2010 Nov; 92(11):1587-96. PubMed ID: 20685328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helix D elongation and allosteric activation of antithrombin.
    Belzar KJ; Zhou A; Carrell RW; Gettins PG; Huntington JA
    J Biol Chem; 2002 Mar; 277(10):8551-8. PubMed ID: 11741963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The region of antithrombin interacting with full-length heparin chains outside the high-affinity pentasaccharide sequence extends to Lys136 but not to Lys139.
    Arocas V; Turk B; Bock SC; Olson ST; Björk I
    Biochemistry; 2000 Jul; 39(29):8512-8. PubMed ID: 10913257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Arg46 and Arg47 of antithrombin in heparin binding.
    Arocas V; Bock SC; Olson ST; Björk I
    Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet factor 4 neutralizes heparan sulfate-enhanced antithrombin inactivation of factor Xa by preventing interaction(s) of enzyme with polysaccharide.
    Fiore MM; Kakkar VV
    Biochem Biophys Res Commun; 2003 Nov; 311(1):71-6. PubMed ID: 14575696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saturation Mutagenesis of the Antithrombin Reactive Center Loop P14 Residue Supports a Three-step Mechanism of Heparin Allosteric Activation Involving Intermediate and Fully Activated States.
    Roth R; Swanson R; Izaguirre G; Bock SC; Gettins PGW; Olson ST
    J Biol Chem; 2015 Nov; 290(47):28020-28036. PubMed ID: 26359493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of arginine 129 in heparin binding and activation of antithrombin.
    Desai U; Swanson R; Bock SC; Bjork I; Olson ST
    J Biol Chem; 2000 Jun; 275(25):18976-84. PubMed ID: 10764763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation.
    Richard B; Swanson R; Olson ST
    J Biol Chem; 2009 Oct; 284(40):27054-64. PubMed ID: 19661062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
    Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
    Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparanase multiple effects in cancer.
    Nadir Y; Brenner B
    Thromb Res; 2014 May; 133 Suppl 2():S90-4. PubMed ID: 24862152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
    Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
    Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase procoagulant activity in cancer progression.
    Nadir Y; Brenner B
    Thromb Res; 2016 Apr; 140 Suppl 1():S44-8. PubMed ID: 27067977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the heparin-binding domain of antithrombin.
    Wu YI; Sheffield WP; Blajchman MA
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):83-95. PubMed ID: 8180343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.